7Baggers
 how 89bio inc. (etnb) affects rotational strategy timing  news.stocktradersdaily.com Thu, 06 Nov 2025 01:04:01 GMT
 will 89bio inc. stock see insider buying - take profit & reliable entry point trade alerts  Fundação Cultural do Pará Wed, 05 Nov 2025 23:54:07 GMT
 jennison associates llc makes new investment in 89bio $etnb  MarketBeat Sun, 02 Nov 2025 08:55:46 GMT
 roche purchases shares in tender offer for 89bio, inc  富途牛牛 Sun, 02 Nov 2025 07:00:00 GMT
 roche to acquire 89bio in deal worth up to $3.5 billion  MSN Sat, 01 Nov 2025 10:13:19 GMT
 89bio (etnb) sees cantor fitzgerald confirm overweight rating |  GuruFocus Fri, 31 Oct 2025 15:07:40 GMT
 89bio (etnb) projected to post earnings on thursday  MarketBeat Fri, 31 Oct 2025 11:15:10 GMT
 89bio completes merger and delists from nasdaq  The Globe and Mail Fri, 31 Oct 2025 07:00:00 GMT

89bio, Inc
(NASDAQ:ETNB) 

ETNB stock logo

89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is BIO89-100, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalc...

Founded: 2018
IPO Price: $16 (Nov 11, 2019)
Full Time Employees: 25
CEO: Rohan Palekar  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends